RTOG-0815

Closed to Accrual

Return to Protocol Table

A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer

Principal Investigator

Alvaro Martinez, MD FACR

Status

Closed to Accrual

Date Closed to Accrual

March 07 2016

Disease Site

Genitourinary [GU]

Prostate

Phase

III

Developmental Therapeutics

Primary Objective

Data Collection Notice:

Data for this trial is being collected via the NRG/RTOG Data Center.

Patient Population

Target Accrual

1520

Protocol Documents

Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.